Table 2.
The percent inhibition of alpha-amylase and alpha-glucosidase of the synthesized compounds.
| Compound | Conc. (µg/ml) | % inhibitions (α-glucosidase) | IC50 (μg/ml) | % inhibitions (α-amylase) | IC50 (μg/ml) |
|---|---|---|---|---|---|
| BW1 | 500 | 89.08 ± 1.04ns | 10.49 | 81.60 ± 0.00∗∗∗ | 13.90 |
| 250 | 83.45 ± 0.90ns | 75.32 ± 0.40∗∗∗ | |||
| 125 | 76.58 ± 0.63ns | 71.78 ± 0.44∗∗∗ | |||
| 62.50 | 70.40 ± 0.20ns | 65.08 ± 0.66∗∗∗ | |||
| 31.25 | 65.80 ± 0.90ns | 57.40 ± 0.40∗∗∗ | |||
|
| |||||
| BW2 | 500 | 87.36 ± 0.49∗ | 10.81 | 78.69 ± 0.14∗∗∗ | 15.34 |
| 250 | 81.34 ± 0.55∗ | 73.14 ± 0.49∗∗∗ | |||
| 125 | 74.39 ± 0.49∗∗∗ | 67.44 ± 0.15∗∗∗ | |||
| 62.50 | 68.47 ± 0.52∗∗∗ | 63.72 ± 0.11∗∗∗ | |||
| 31.25 | 62.44 ± 0.55∗∗ | 55.85 ± 0.17∗∗∗ | |||
|
| |||||
| BW3 | 500 | 77.85 ± 2.24∗∗∗ | 12.15 | 75.35 ± 0.89∗∗∗ | 18.20 |
| 250 | 72.08 ± 0.47∗∗∗ | 71.36 ± 1.15∗∗∗ | |||
| 125 | 67.90 ± 0.96∗∗∗ | 67.62 ± 0.03∗∗∗ | |||
| 62.50 | 63.28 ± 0.57∗∗∗ | 62.16 ± 0.12∗∗∗ | |||
| 31.25 | 57.47 ± 0.56∗∗∗ | 54.67 ± 0.35∗∗∗ | |||
|
| |||||
| Acarbose | 500 | 92.23 ± 0.22 | 8.20 | 87.75 ± 0.42 | 10.35 |
| 250 | 86.45 ± 0.90 | 82.47 ± 0.71 | |||
| 125 | 80.90 ± 0.60 | 76.20 ± 0.49 | |||
| 62.50 | 73.00 ± 0.30 | 69.42 ± 1.55 | |||
| 31.25 | 67.90 ± 0.45 | 63.62 ± 0.58 | |||
All values are taken as mean ± SEM (n = 3), and two-way ANOVA followed by Bonferroni test were followed. Values significantly different as compared to standard drug; ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, and ns: not significant.